(Q36581377)

15 August 2017

Evaluation of chemosensitivity prediction using quantitative dose-response curve classification for highly advanced/relapsed gastric cancer (English)

1 reference

15 August 2017

Teppei Matsuo

1

1 reference

15 August 2017

Satoshi S Nishizuka

2

1 reference

15 August 2017

Kazushige Ishida

3

1 reference

15 August 2017

Fumitaka Endo

4

1 reference

15 August 2017

Hirokatsu Katagiri

5

1 reference

15 August 2017

Kohei Kume

6

1 reference

15 August 2017

Miyuki Ikeda

7

1 reference

15 August 2017

Keisuke Koeda

8

1 reference

15 August 2017

Go Wakabayashi

9

1 reference

15 August 2017

22 January 2013

1 reference

World Journal of Surgical Oncology

15 August 2017

1 reference

15 August 2017

11

1 reference

15 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1186/1477-7819-11-11

15 August 2017

0 references

cites work

Alterations in cell proliferation related gene expressions in gastric cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562164

Docetaxel and capecitabine for advanced gastric cancer: investigating dose-dependent efficacy in two patient cohorts

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562164

Randomized phase III study comparing the efficacy and safety of irinotecan plus S-1 with S-1 alone as first-line treatment for advanced gastric cancer (study GC0301/TOP-002)

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562164

S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562164

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562164

Learning a predictive model for growth inhibition from the NCI DTP human tumor cell line screening data: does gene expression make a difference?

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562164

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562164

Ovarian cancer: strategies for overcoming resistance to chemotherapy

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562164

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562164

In vitro sensitivity assays in cancer: a review, analysis, and prognosis

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562164

A radiometric method for evaluation of chemotherapy sensitivity: results of screening a panel of human breast cancer cell lines.

9 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562164

Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562164

In vitro evaluation of dose-response curve for paclitaxel in breast cancer.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562164

Randomized trial of adjuvant chemotherapy with mitomycin, Fluorouracil, and Cytosine arabinoside followed by oral Fluorouracil in serosa-negative gastric cancer: Japan Clinical Oncology Group 9206-1.

20 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3562164

High in vitro-in vivo correlation of drug response using sponge-gel-supported three-dimensional histoculture and the MTT end point

20 September 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23339659

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

The usefulness of the ATP assay with serum-free culture for chemosensitivity testing of gastrointestinal cancer

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23339659

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Potential of the histoculture drug-response assay to contribute to cancer patient survival

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/23339659

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1477-7819-11-11

1 reference

Dimensions Publication ID

15 August 2017

0 references

1 reference

15 August 2017

1 reference